Skip to main content
Equibles

Mark Singleton

CFO

Bioventus Inc. (BVS)

Equibles does not estimate personal net worth.

Get an email with a short summary when Bioventus Inc. publishes a filing, an earnings call transcript or a press release.

Get BVS alerts

About Mark Singleton

Mark Singleton is recorded as CFO at Bioventus Inc. (BVS). The newest filing on record that lists Mark Singleton as CFO at Bioventus Inc. (BVS) is dated April 22, 2026. The proxy statement of Bioventus Inc. reports total compensation of $1,897,062 for Mark Singleton in fiscal 2025, including a base salary of $499,948. Disclosed compensation is on record for 4 fiscal years. Mark Singleton has spoken on 18 earnings calls and 1 other investor event across 1 company, most recently for Bioventus Inc. on August 5, 2026. Bioventus Inc. is classified in the Medical Devices industry within the Healthcare sector. Other leadership on record at Bioventus Inc. includes Anthony Bihl (CEO), Anthony P. Bihl III (CEO and Board Member), Robert Claypoole (CEO and Board Member) and 7 others.

Mark Singleton on recent calls

“Let me start by highlighting that our performance this quarter reflects the strength of our strategy and our discipline to execution against the investment thesis we outlined.”
CFO, Bioventus Inc. Second Quarter 2026 Earnings Conference Call ·
“BioVentus is a $568 million revenue company as of 2025. Our guidance for 2026 is $605 million. We participate in markets of $6 billion plus, so a lot of opportunity.”
CFO, Goldman Sachs Global Healthcare Conference ·
“Let me begin by saying that we had a strong first quarter, and we are well positioned to increase investment in our future growth, while continuing to strengthen our balance sheet with robust cash flow.”
CFO, Bioventus Inc. Q1 FY2026 Earnings Call ·
“Let me begin by saying that I am proud of our team's hard work and dedication to transform BioVentus and significantly improve our financial results over the past few years.”
CFO, Bioventus Inc. Q4 FY2025 Earnings Call ·
“Let me begin by saying that I am proud of our team's hard work and dedication to transform BioVentus. Over the last eight quarters, we have generated at least mid-single-digit organic revenue growth, significantly improved profitability, and strengthened our balance sheet.”
CFO, Bioventus Inc. Q3 FY2025 Earnings Call ·

Affiliation history

Company network

Leadership on record at Bioventus Inc.

Executive compensation

Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.

Fiscal year Company Salary Total
2025 Bioventus Inc. (BVS) $499,948 $1,897,062
2024 Bioventus Inc. (BVS) $473,825 $2,087,676
2023 Bioventus Inc. (BVS) $452,438 $1,058,233
2022 Bioventus Inc. (BVS) $336,932 $2,462,453

Recent activity

Show 7 earlier activities